Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
10.3802/jgo.2021.32.e27
Saved in:
Main Authors: | Tan, David SP, Chan, Jack Junjie, Hettle, Robert, Ghosh, Wrik, Viswambaram, Amrita, Yu, Cindy Chen |
---|---|
Other Authors: | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
Format: | Article |
Published: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/185760 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
by: Tan, DS, et al.
Published: (2021) -
A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
by: Lee, Yong Jae, et al.
Published: (2021) -
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
by: Kim, YN, et al.
Published: (2023) -
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant
by: Soon, Jonathan Jian Hao, et al.
Published: (2023) -
cis-Platinum-based chemotherapy in management of malignant ovarian germ cell tumors
by: V. Linasmita, et al.
Published: (2018)